Related Experiment Videos
Premenopausal breast cancer after in-utero exposure to stilboestrol
Lancet (London, England)
|August 3, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2-associated high-risk HER2-negative early breast cancer: updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
CT surveillance, patterns of recurrence and eligibility for salvage therapy after curative intent treatment for unresectable stage III non small cell lung cancer.
Lung cancer (Amsterdam, Netherlands)·2026
Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2- breast cancer and residual disease after neoadjuvant chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Correction: Titmuss et al. Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. Int. J. Mol. Sci. 2023, 24, 5869.
International journal of molecular sciences·2024
Immune Activation following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study.
International journal of molecular sciences·2023
Conversational diagnostic artificial intelligence in ambulatory primary care: a prospective feasibility study.
Lancet (London, England)·2026
Migraine.
Lancet (London, England)·2026
Governing the digital determinants of health for children and young people: a global public health imperative.
Lancet (London, England)·2026